Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety

Stereotactic Body Radiation Therapy for the Management of Hepatocellular Carcinoma: Efficacy and Safety

This study aimed to describe patient characteristics, treatment efficacy, and safety in patients with hepatocellular carcinoma (HCC) undergoing stereotactic body radiation therapy (SBRT). We retrospectively analyzed data of 318 patients with 375 HCC treated between June 2007 and December 2018. Effic...

Full description

Bibliographic Details
Main Authors:	Isaure Roquette, Emilie Bogart, Thomas Lacornerie, Massih Ningarhari, Jean-Emmanuel Bibault, Marie-Cecile Le Deley, Eric F. Lartigau, David Pasquier, Xavier Mirabel
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Cancers
Subjects:	stereotactic body radiation therapy hepatocellular carcinoma SBRT HCC radiotherapy
Online Access:	https://www.mdpi.com/2072-6694/14/16/3892

Similar Items

Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma
by: Eleni Gkika, et al.
Published: (2017-07-01)

Stereotactic body radiation therapy (SBRT) for definitive treatment and as a bridge to liver transplantation in early stage inoperable Hepatocellular carcinoma
by: Assaf Moore, et al.
Published: (2017-10-01)

Stereotactic body radiotherapy as a viable treatment on extracranial oligometastases in melanoma patients: a retrospective multicentric study
by: Victorine Trentesaux, et al.
Published: (2024-03-01)

Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies
by: Yanyan Long, et al.
Published: (2021-04-01)

Current Understanding of Ablative Radiation Therapy in Hepatocellular Carcinoma
by: Mathew AS, et al.
Published: (2021-06-01)

Prognostic factors affecting local control of hepatic tumors treated by stereotactic body radiation therapy
by: Dewas Sylvain, et al.
Published: (2012-10-01)

Comparing stereotactic ablative radiotherapy (SABR) versus re-trans-catheter arterial chemoembolization (re-TACE) for hepatocellular carcinoma patients who had incomplete response after initial TACE (TASABR): a randomized controlled trial
by: Liang-Cheng Chen, et al.
Published: (2019-03-01)

Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturityKey points
by: Shirley Lewis, et al.
Published: (2022-08-01)

Developments in Stereotactic Body Radiotherapy
by: Anoop Haridass
Published: (2018-12-01)

Stereotactic radiotherapy: An educational narrative review
by: Agha Muhammad Hammad Khan, et al.
Published: (2024-03-01)

A Review of Ongoing Trials of Stereotactic Ablative Radiotherapy for Oligometastatic Cancers: Where Will the Evidence Lead?
by: Faiez Al-Shafa, et al.
Published: (2019-06-01)

Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer: A Retrospective Multicenter Study
by: Pauline Lemoine, et al.
Published: (2021-10-01)

Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study
by: Yongbiao Chen, et al.
Published: (2023-03-01)

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
by: Tomoki Kimura, et al.
Published: (2022-09-01)

Stereotactic body radiation therapy (SBRT) in patients with hepatocellular carcinoma and oligometastatic liver disease
by: Sabine Gerum, et al.
Published: (2018-05-01)

Long-Term Outcomes of Stereotactic Body Radiotherapy (SBRT) for Intraprostatic Relapse after Definitive Radiotherapy for Prostate Cancer: Patterns of Failure and Association between Volume of Irradiation and Late Toxicity
by: Marcin Miszczyk, et al.
Published: (2023-02-01)

Stereotactic ablative radiotherapy for primary renal cell carcinoma
by: Daniel X. Yang, et al.
Published: (2024-01-01)

Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma
by: Eleni Gkika, et al.
Published: (2017-11-01)

Outcomes Following Stereotactic Body Radiotherapy with Intensity-Modulated Therapy versus Three-Dimensional Conformal Radiotherapy in Early Stage Non-Small Cell Lung Cancer
by: Mix M, et al.
Published: (2019-12-01)

Outcome of lung oligometastatic patients treated with stereotactic body irradiation
by: Guillaume Virbel, et al.
Published: (2022-07-01)

A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases
by: Fumagalli Ingrid, et al.
Published: (2012-09-01)

Image-Guided Robotic Stereotactic Radiation Therapy with Fiducial-Free Tumor Tracking for Lung Cancer
by: Bibault Jean-Emmanuel, et al.
Published: (2012-06-01)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2019-09-01)

MRI-guided stereotactic ablative radiation therapy for metachronously recurrent pulmonary oligometastases from hepatocellular carcinoma after failure of systemic therapy
by: Yukihiro Hama, et al.
Published: (2023-06-01)

Dosimetric Benefit of Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy of Liver Metastases
by: Fabian Weykamp, et al.
Published: (2022-12-01)

Adrenal oligometastasis cured with stereotactic ablative radiotherapy
by: Julia Malone, BSC, et al.
Published: (2020-11-01)

Efficacy and Tolerance of Post-operative Hypo-Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases
by: Geoffrey Martinage, et al.
Published: (2019-03-01)

Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma
by: Rohit K. Raj, et al.
Published: (2023-12-01)

Effect of stereotactic radiotherapy on immune microenvironment of lung cancer
by: Yao Xiao, et al.
Published: (2022-09-01)

Bibliometric Analysis of the Top-Cited Publications and Research Trends for Stereotactic Body Radiotherapy
by: Yanhao Liu, et al.
Published: (2021-12-01)

Application of stereotactic body radiotherapy in advanced pancreatic cancers in Australia
by: Laurence Kim, et al.
Published: (2019-03-01)

Stereotactic body radiotherapy for recurrent and oligometastatic soft tissue sarcoma
by: Xiao-Yao Feng, et al.
Published: (2022-09-01)

A Multicenter Phase 2 Study of Ultrahypofractionated Stereotactic Boost After External Beam Radiotherapy in Intermediate-risk Prostate Carcinoma: A Very Long-term Analysis of the CKNO-PRO Trial
by: David Pasquier, et al.
Published: (2023-08-01)

Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRT
by: Yasutaka Ogawa, et al.
Published: (2018-07-01)

A multicenter prospective phase II study of postoperative hypofractionated stereotactic body radiotherapy (SBRT) in the treatment of early-stage oropharyngeal and oral cavity cancers with high risk margins: the STEREO POSTOP GORTEC 2017-03 trial
by: Julian Biau, et al.
Published: (2020-08-01)

Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
by: Kevin T. Tran, et al.
Published: (2023-03-01)

Stereotactic body radiotherapy for extra-cranial oligoprogressive or oligorecurrent small-cell lung cancer
by: Antonin Levy, et al.
Published: (2023-07-01)

Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study
by: Jeong Yun Jang, et al.
Published: (2022-09-01)

Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series
by: Ying-Fu Wang, et al.
Published: (2021-01-01)

Stereotactic Body Radiotherapy as Primary Therapy for Head and Neck Cancer in the Elderly or Patients with Poor Performance
by: Arya eAmini, et al.
Published: (2014-10-01)